Peer Review History

Original SubmissionJune 9, 2021
Decision Letter - Christopher Staley, Editor

PONE-D-21-16611

Development and Characterization of an Oral Microbiome Transplant Among Australians for the Treatment of Dental Caries and Periodontal Disease: A Study Protocol.

PLOS ONE

Dear Dr. Nath,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In addition to clarification of the results throughout, both reviewers found the concept of the 'super donor' to be poorly described, if not ill conceived. Due to the plasiticity in microbiome between individuals, it is likely to the authors' benefit to more carefully consider this idea.

Please submit your revised manuscript by Aug 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Christopher Staley, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please update the Animal ethics statement to include the date when approval was received

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript aims to develop and characterize an Oral Microbiome Transplant (OMT) for the treatment of caries and periodontal disease. Supragingival plaque samples would be collected from healthy participants to find donors suitable for microbial transplantation. Based on the current protocol, a novel in vitro flow cell model combined with microscopic examination and DNA sequencing were be used to describe the composition and functions of the donors. Hydrogels would be used to deliver microbiota for OMT. The effectiveness of OMT would be assessed using caries and periodontitis animal models. Although the current research would provide preliminary results of the feasibility of oral microbiome transplant, I still see some major areas of concern that I think need to be addressed before this manuscript is ready for primetime.

1. What is the specific definition of “super donor”? Authors mentioned that it is prudent to understand the variation and functions of a healthy oral microbiome and hence define a “super donor”, however, authors never presented data in support of any of these claims.

2. In Rodent periodontitis model, why not use silk-ligature for induction of experimental periodontitis? Also, why not include the application of a broad-spectrum antimicrobial agent before OMT?

3. “The use of hydrogel for OMT delivery provides a unique opportunity to seed the micro-organisms onto the surface of teeth for a prolonged period” Any data to support these claims?

4. Safety concerns in the application of OMT are similar to those for oral probiotics, as transplanted biofilms should possess a high degree of genetic stability. It is critical to determine whether oral biofilms should be transplanted directly from donors to patients, or pre-treated with methods that eliminate pathogenic organisms prior to transplantations. How can these problems be solved according to the current protocol?

5. In OMT, transplanted biofilms must exhibit the capacity to effectively endure the selective pressure of the environment. Why do authors choose hydrogels to deliver microbiota for OMT? Please specify in the text.

6. The discussion part should focus more on the advantages of this experimental method

Reviewer #2: The protocol seems to make sense, however the concept of the super donor seems a bit naive at this point. None knows what is the "healthiest" microbiota is and how is it supposed to be characterized. The idea of an in vitro "factory" for the beneficial microbiota is very interesting. The weakness of the protocol is that it artificially induces caries and periodontitis in rats and then attempts "fixing" it. It would be much more interesting to test the OMT with naturally occurring periodontitis in dogs or humans directly. Of note, before COVID, we were able to obtain an IRB approval for a direct human-to-human OMT for volunteer couples. (Our study did not move forward due to COVID) Perhaps the authors of the paper may consider something along these lines as an addition to their protocol. This is because if OMT could be shown to work in principle in a simple setting, there will be a strong motivation to continue with the "super donor".

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: ALEXANDER POZHIKOV

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: 0628plosone.docx
Revision 1

We thank the reviewers for their comments. We have addressed each comment below and in the main text, and we believe that the manuscript now more clearly explains the strategies behind our approach.

The comments from the reviewer:

This manuscript aims to develop and characterize an Oral Microbiome Transplant (OMT) for the treatment of caries and periodontal disease. Supragingival plaque samples would be collected from healthy participants to find donors suitable for microbial transplantation. Based on the current protocol, a novel in vitro flow cell model combined with microscopic examination and DNA sequencing were be used to describe the composition and functions of the donors. Hydrogels would be used to deliver microbiota for OMT. The effectiveness of OMT would be assessed using caries and periodontitis animal models. Although the current research would provide preliminary results of the feasibility of oral microbiome transplant, I still see some major areas of concern that I think need to be addressed before this manuscript is ready for primetime.

1. What is the specific definition of “super donor”? Authors mentioned that it is prudent to understand the variation and functions of a healthy oral microbiome and hence define a “super donor”, however, authors never presented data in support of any of these claims.

Author’s response: This concept is borrowed from fecal microbiota transplant literature (reviewed in Wilson, et al. Front. Cell. Infect. Microbiol., 2019). An oral microbiota ‘super donor’ is now defined in the text in the context of this approach and discussed in great detail in the introduction (page 8, Line 169-190) and discussion (page 22, line 486-488, 496-508).

2. In Rodent periodontitis model, why not use silk-ligature for induction of experimental periodontitis? Also, why not include the application of a broad-spectrum antimicrobial agent before OMT?

Author’s response: This is a wonderful suggestion. We now provide a rational as to why this approach was not selected, but it would be useful in the exploration of OMT efficacy for a multitude of reasons. We have now included it in the discussion (page 24, line 550-562).

3. “The use of hydrogel for OMT delivery provides a unique opportunity to seed the micro-organisms onto the surface of teeth for a prolonged period” Any data to support these claims?

Author’s response: As OMT therapy has not yet been delivered yet in humans (which we now make clear in the introduction of the paper), there are not any references to support this claim. Therefore, we have clarified our statement and provided further rational to support the selection of hydrogel developed in OMTs (page 23-24, line 529-546).

4. Safety concerns in the application of OMT are similar to those for oral probiotics, as transplanted biofilms should possess a high degree of genetic stability. It is critical to determine whether oral biofilms should be transplanted directly from donors to patients, or pre-treated with methods that eliminate pathogenic organisms prior to transplantations. How can these problems be solved according to the current protocol?

Author’s response: We agree that this is a critical issue. We have added a brief discussion of this into manuscript in the context of our in vivo model (Page 19, line 432-434, and page 20, line 458-462), although directly testing this will likely require early clinical trials in humans. In murine models for caries and periodontitis, prior to application of OMT, full mouth debridement and disinfection would be carried out. For safety assessments in murine models, discomfort would be measured by vital parameters and any adverse reactions (page 20-21, line 477-479).

5. In OMT, transplanted biofilms must exhibit the capacity to effectively endure the selective pressure of the environment. Why do authors choose hydrogels to deliver microbiota for OMT? Please specify in the text.

Author’s response: We provide an improved rational for why hydrogels were selected in the discussion ( Page 23-24, line 523-546) and also include a brief discussion of other methods that could be employed, if hydrogels fail (Page 16). We will test the efficacy of delivering OMT in hydrogels in murine models. In addition, other modes of delivery would also be tested such as buffers, varnishes and mouthwash (page 16-17, line 383-386).

6. The discussion part should focus more on the advantages of this experimental method.

Author’s response: We have completely revamped the discussion to include significant discussion of the advantages of this approach (Page 212, line 496-508, page 23 line 520-522, line 523-527, line 540-546, 563-564).

Attachments
Attachment
Submitted filename: ResponseTo Reviewer.docx
Decision Letter - Christopher Staley, Editor

Development and Characterization of an Oral Microbiome Transplant Among Australians for the Treatment of Dental Caries and Periodontal Disease: A Study Protocol.

PONE-D-21-16611R1

Dear Dr. Nath,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Christopher Staley, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #2: Yes

Reviewer #3: No

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #2: Yes

Reviewer #3: No

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #2: Yes

Reviewer #3: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: My major concern was the use of the hydrogel and the definition of the "super donor". Although one may argue if the hydrogel use is warranted, the authors gave a satisfactory rationale. Still, I would leave a room for other potential modes for delivering the OMT other than a hydrogel.

Reviewer #3: The authors are strongly encouraged to perform the proposed study!!!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Alexander Pozhitkov

Reviewer #3: No

Formally Accepted
Acceptance Letter - Christopher Staley, Editor

PONE-D-21-16611R1

Development and characterization of an oral microbiome transplant among Australians for the treatment of dental caries and periodontal disease: A study protocol.

Dear Dr. Nath:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Christopher Staley

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .